George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksIxico Share News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.625
Bid: 8.50
Ask: 8.75
Change: 0.00 (0.00%)
Spread: 0.25 (2.941%)
Open: 8.625
High: 8.625
Low: 8.625
Prev. Close: 8.625
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Ixico revenue falls, Solid State boosts profit

Tue, 05th Dec 2023 14:31

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Ixico PLC - London-based precision analytics company working to advance investigational therapies for neurological diseases - Revenue for the year that ended on September 30 falls 23% to GBP6.7 million from GBP8.6 million the year before. Company swings to GBP1.4 million pretax loss following a GBP885,000 profit. Total operating expenses increase to GBP5.1 million from GBP5.0 million. Ixico says revenue drop was expected and caused by the now-realised impact of clients ceasing multiple large "failed" trials across 2021 and early 2022. Expects to deliver roughly flat revenue in the current financial year before returning to growth in 2025.

----------

Supply@Me Capital PLC - London-based fintech platform provider - Says it has so far received GBP1.4 million from The AvantGarde Group SpA as a result of contractual payments. An additional GBP1.5 million remains outstanding. Also says it has made significant progress in the formalisation of its first White-Label IM agreement with an Italian banking group with a transaction valued at up to EUR10 million. Company is also working to finalise a framework to issue security tokens up to USD100 million to be subscribed in tranches.

----------

Lindsell Train Investment Trust PLC - London-based, rail-focused investment trust - Net asset value at September 30 is GBP968.75 per share, down from GBP1,056.95 at March 31. NAV total return for the six months to September 30 is negative 3.6%, underperforming the MSCI World Index with positive 4.5%. Says performance was impacted by high interest rates and inflation, and believes it may have to reduce its dividend. Notes reduced investor risk appetites and increased market volatility.

----------

Marechale Capital PLC - London-based corporate finance adviser - Revenue for the half year that ended on October 31 increased 91% to GBP320,603 from GBP168,001. Cost of sales more than doubles to GBP226,790 from GBP95,981. Pretax loss narrows to GBP155,803 from GBP179,502. Marechale says market is still challenging, especially in the hospitality sector, but that it remains positive about the outlook for its investments.

----------

Anglesey Mining PLC - Base metals miner with operations in North Wales, Sweden and Canada - Says drilling of the NCZ001 hole in the Northern Copper Zone at its Parys Mountain project on the Isle of Anglesey commenced on October 27, and is expected to complete over the next week. Expects results in the first quarter of 2024. Says initial logging suggests sulphide mineralisation commencing at around 350 metres deep. Chief Executive Jo Battershill says initial core is "very encouraging" as "we are seeing a significant amount of quartz veins within the system..[which] contain encouraging amounts of chalcopyrite, sphalerite, and galena – the key minerals that host copper, zinc and lead."

----------

Psych Capital PLC - London-based psychedelic medicines media firm and investor - Oscillate PLC continues to own 46.0 million shares in Psych, representing 12.75% of its issued share capital, following Psych's acquisition of Short Wave Pharma Inc which completed in November. Oscillate says it will continue to assess the investment to ascertain an exit opportunity. Says it meanwhile remains "optimistic at the advances that the Short Wave acquisition represents in the innovative psychedelics space." Oscillate also says that trials are due to start in the first quarter of 2024.

----------

Solid State PLC - Redditch, England-based supplier & design-in manufacturer of computing, power, and communications products - Pretax profit for the six months to September 30 is GBP6.1 million, up 45% from GBP4.2 million the prior year. Revenue increases 48% to GBP88.1 million from GBP59.4 million. Company declares 7.0 pence per share interim dividend, up 8% from 6.5p the year before. Says it is confident in meeting expectations for full-year results thanks to "record billings" and a "stable six-month order book". Open order book at October 31 stood at GBP108.6 million, slightly down from GBP112.5 million at September 30, 2022.

----------

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
15 Apr 2024 14:25

Ixico inks supply agreement with Life Molecular Imaging for Neuraceq

(Alliance News) - Ixico PLC on Monday said it has signed a supply agreement with Life Molecular Imaging GmbH, in a deal the company says will complement its "well-established PET imaging services and image data analytics".

Read more
15 Apr 2024 09:31

Ixico inks supply agreement with LMI

(Sharecast News) - Analytics company Ixico has inked a supply agreement with Life Molecular Imaging that will see it supply that latter's Neuraceq Amyloid PET tracer for use in pharma-sponsored clinical trials.

Read more
3 Apr 2024 12:08

IN BRIEF: Ixico inks collaboration with IMEKA Solutions

Ixico PLC - neuroscience focused advanced analytics company - Collaborates with IMEKA Solutions Inc, to provide access to Imeka's suite of services for white matter imaging deployed in Alzheimer's disease and multiple sclerosis clinical trials, amongst other CNS indications. Says Imeka's diffusion MRI algorithms will be made available to Ixico's global biopharma clients.

Read more
13 Mar 2024 12:39

Ixico shares fall 20% as revenue to decline, hit by delays to projects

(Alliance News) - Ixico PLC shares dropped sharply on Wednesday, after it said delays to projects will result in lower annual revenue.

Read more
13 Mar 2024 12:25

Ixico warns on 2024 revenue amid contract delays

(Sharecast News) - Medical imaging analytics company Ixico said in a trading update on Wednesday that, despite ongoing progress in expanding its opportunities pipeline, the first half of 2024 had been marked by extended contracting cycles and delays in securing certain new contracts.

Read more
13 Mar 2024 11:12

AIM WINNERS & LOSERS: Woodbois rises as plots Mozambique exit

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
13 Mar 2024 08:51

LONDON MARKET OPEN: FTSE 100 slips but CAC and DAX hit record highs

(Alliance News) - European equities kicked off Wednesday largely on the front foot, picking up the baton after US stocks resumed an "inexorable march" on Tuesday, after shaking off a hot US inflation reading.

Read more
18 Jan 2024 16:29

UK shareholder meetings calendar - next 7 days

Friday 19 January 
Cardiff Property PLCAGM
Character Group PLCAGM
Focusrite PLCAGM
Substrate Artificial Inteligence SAGM re investment agreement and issue of equity
Monday 22 January 
Highcroft Investments PLCGM re de-listing from LSE and relisting on TISE
Smart Metering Systems PLCGM & court meeting re takeover by funds advised by KKR
Tuesday 23 January 
C4X Discovery Holdings PLCAGM
Marston's PLCAGM
Mitchells & Butlers PLCAGM
Wednesday 24 January 
Henderson Far East Income LtdAGM
Lowland Investment Co PLCAGM
Tracsis PLCAGM
Thursday 25 January 
Alteration Earth PLCAGM
Britvic PLCAGM
Greencore Group PLCAGM
Henderson European Focus Trust PLCAGM
Ixico PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
12 Jan 2024 15:51

Ixico CEO to step down by end of year

(Sharecast News) - Medical imaging analytics company Ixico announced on Friday that its chief executive officer Giulio Cerroni planned to retire from his position, and as a director, by the end of 2024.

Read more
12 Jan 2024 10:16

Ixico CEO Cerroni to retire by end of 2024; starts succession search

(Alliance News) - Ixico PLC on Friday said that Chief Executive Officer Giulio Cerroni will retire from his role by the end of 2024.

Read more
29 Sep 2023 14:19

EARNINGS AND TRADING: Barkby revenue dips; Ixico hurt by trial delays

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
29 Sep 2023 13:08

Ixico full-year earnings could slightly exceed forecasts

(Sharecast News) - Advanced medical imaging analytics specialist Ixico said in an update on Friday that its earnings for the financial year would either meet or exceed market predictions, even though it faced a minor revenue shortfall.

Read more
18 Jul 2023 16:55

TRADING UPDATES: Andrada raises GBP7.7 million; Ixico signs contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
14 Jun 2023 14:17

Ixico awarded new £2m, four-year contract

(Sharecast News) - Medical imaging and analytics specialist Ixico has been awarded a new contract by an existing client, it announced on Wednesday, to provide imaging services for the extension study of their phase 2b trial for Huntington's disease (HD).

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.